These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5391697)

  • 1. Modification of certain central nervous effects of haloperidol during long-term treatment in the mouse and rat.
    György L; Pfeifer KA; Hajtman B
    Psychopharmacologia; 1969; 16(3):223-33. PubMed ID: 5391697
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mechanism of postetorphine catalepsy. Effects of clotiapine, haloperidol and rompun on postetorphine changes in concentrations of dopamine and noradrenaline in central nervous system of rats.
    Kania BF
    Acta Physiol Pol; 1980; 31(1):9-16. PubMed ID: 6103632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol catalepsy consolidation in the rat as a model of neuromodulatory integration.
    Bazyan AS; Getsova VM; Orlova NV
    Neuroscience; 2000; 99(2):279-88. PubMed ID: 10938433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of haloperidol on the central nervous system].
    Vinogradov VV; Krylov SS; Snegirev EA; Sysoeva AF; Khasabova VA
    Farmakol Toksikol; 1967; 30(2):131-4. PubMed ID: 4971063
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z; Szponar J; Matuszek B; Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol in large doses reduces the cataleptic response and increases noradrenaline metabolism in the brain of the rat.
    Toru M; Takashima M
    Neuropharmacology; 1985 Mar; 24(3):231-6. PubMed ID: 4039420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies with some newly synthesized phenothiazines exhibiting lesser extrapyramidal reactions.
    Sharma VN; Mital RL; Banerjee SP; Sharma HL
    Jpn J Pharmacol; 1969 Jun; 19(2):211-23. PubMed ID: 5308826
    [No Abstract]   [Full Text] [Related]  

  • 8. 4'-Fluoro-4-(1,4,5,6-tetrahydroazepinol[4,5-b]indol-3(2H)-yl)butyrophenones.
    Hester JB; Rudzik AD; Keasling HH; Veldkamp W
    J Med Chem; 1970 Jan; 13(1):23-6. PubMed ID: 5460894
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of albumin degradation products (ADP) on the central action of catecholamines.
    Tarasiewicz S; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):691-6. PubMed ID: 1034926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different central mediation of the stimulant effects of amphetamine and its p-chloro analogue.
    Frey HH; Magnussen MP
    Biochem Pharmacol; 1968 Jul; 17(7):1299-307. PubMed ID: 5659777
    [No Abstract]   [Full Text] [Related]  

  • 12. [High dosage haloperidol reduces cataleptic response with increased noradrenaline metabolism in the rat brain areas].
    Takashima M; Toru M
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):149-58. PubMed ID: 6687201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
    Kostowski W; Czlonkowski A
    Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolism of dopamine and norepinephrine in rat brain after acute and chronic administration of haloperidol, loxapine and clozapine].
    Bürki HR
    Arzneimittelforschung; 1974 Jul; 24(7):983-4. PubMed ID: 4136404
    [No Abstract]   [Full Text] [Related]  

  • 15. Cataleptic action of nitrazepam and brain dopamine function in mice.
    Matsui Y; Deguchi T
    Neuropharmacology; 1977 Apr; 16(4):253-8. PubMed ID: 140329
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for a central noradrenaline receptor stimulation by clonidine.
    Andén NE; Corrodi H; Fuxe K; Hökfelt B; Hökfelt T; Rydin C; Svensson T
    Life Sci; 1970 May; 9(9):513-23. PubMed ID: 4393798
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of monoamines in rotation induced or potentiated by amphetamine after nigral, raphe and mesencephalic reticular lesions in the rat brain.
    Marsden CA; Guldberg HC
    Neuropharmacology; 1973 Mar; 12(3):195-211. PubMed ID: 4266877
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Brahmi Rasayan on the central nervous system.
    Shukia B; Khanna NK; Godhwani JL
    J Ethnopharmacol; 1987; 21(1):65-74. PubMed ID: 3695557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems.
    McMillen BA; Shore PA
    J Pharm Pharmacol; 1978 Jul; 30(7):464-6. PubMed ID: 27622
    [No Abstract]   [Full Text] [Related]  

  • 20. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.
    Andén NE; Grabowska M; Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):43-52. PubMed ID: 6918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.